These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 15953939)

  • 1. Canadian Cardiovascular Society/Canadian Heart Rhythm Society position paper on implantable cardioverter defibrillator use in Canada.
    Tang AS; Ross H; Simpson CS; Mitchell LB; Dorian P; Goeree R; Hoffmaster B; Arnold M; Talajic M; ;
    Can J Cardiol; 2005 May; 21 Suppl A():11A-18A. PubMed ID: 15953939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
    Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C
    Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Canadian Cardiovascular Society commentary on implantable cardioverter defibrillators in Canada: waiting times and access to care issues.
    Simpson CS; O'Neill BJ; Sholdice MM; Dorian P; Kerr CR; Ross DB; Ross H; Brophy JM;
    Can J Cardiol; 2005 May; 21 Suppl A():19A-24A. PubMed ID: 15953940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implantable devices for management of chronic heart failure: defibrillators and biventricular pacing therapy.
    Pires LA
    Curr Opin Anaesthesiol; 2006 Feb; 19(1):69-74. PubMed ID: 16547436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Referring patients for consideration of device treatment of sudden cardiac death and heart failure: incorporating evidence-based therapies within the Canadian health care system.
    Gillis AM
    Can J Cardiol; 2005 May; 21 Suppl A():25A-30A. PubMed ID: 15953941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reducing mortality with device therapy in heart failure patients without ventricular arrhythmias.
    Chapa DW; Lee HJ; Kao CW; Friedmann E; Thomas SA; Anderson J; Bardy GH
    Am J Crit Care; 2008 Sep; 17(5):443-52; quiz 453. PubMed ID: 18776000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex-based differences in cardiac resynchronization therapy and implantable cardioverter defibrillator therapies: effectiveness and use.
    Yarnoz MJ; Curtis AB
    Cardiol Rev; 2006; 14(6):292-8. PubMed ID: 17053376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guidelines for implantable cardioverter defibrillator follow-up in Canada: a consensus statement of the Canadian Working Group on Cardiac Pacing.
    Gillis AM; Philippon F; Cassidy MR; Singh N; Dorian P; Love BA; Kerr CR;
    Can J Cardiol; 2003 Jan; 19(1):21-37. PubMed ID: 12571692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implantable cardioverter defibrillator therapy for primary prevention of sudden cardiac death after myocardial infarction: implications of international guidelines.
    Foley PW; Addison CE; Whinney SB; Patel K; Cunningham D; Frenneaux MP; Leyva F
    Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S131-4. PubMed ID: 19250076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cardiac resynchronization therapy-always with ICD?].
    Stellbrink C
    Herz; 2005 Nov; 30(7):596-600. PubMed ID: 16333584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary prevention of sudden cardiac death using implantable cardioverter defibrillators.
    Ding L; Hua W; Niu H; Chen K; Zhang S
    Europace; 2008 Sep; 10(9):1034-41. PubMed ID: 18559335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 2004 ACC/AHA Guidelines: a perspective and adaptation for Canada by the Canadian Cardiovascular Society Working Group.
    Armstrong PW; Bogaty P; Buller CE; Dorian P; O'Neill BJ;
    Can J Cardiol; 2004 Sep; 20(11):1075-9. PubMed ID: 15457302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biventricular pacing and defibrillator use in chronic heart failure.
    Cesario DA; Turner JW; Dec GW
    Cardiol Clin; 2007 Nov; 25(4):595-603; vii. PubMed ID: 18063163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indications for ICD and cardiac resynchronization therapy for prevention of sudden cardiac death.
    Das M
    Expert Rev Cardiovasc Ther; 2009 Feb; 7(2):181-95. PubMed ID: 19210214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moderate exercise training improves functional capacity, quality of life, and endothelium-dependent vasodilation in chronic heart failure patients with implantable cardioverter defibrillators and cardiac resynchronization therapy.
    Belardinelli R; Capestro F; Misiani A; Scipione P; Georgiou D
    Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):818-25. PubMed ID: 17001224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of implantable-cardioverter-defibrillator trials on clinical management of patients with heart failure.
    Winslow RD; Pinney S; Fuster V
    Nat Clin Pract Cardiovasc Med; 2006 Feb; 3(2):86-93. PubMed ID: 16446777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Canadian Cardiovascular Society/Canadian Heart Rhythm Society 2016 Implantable Cardioverter-Defibrillator Guidelines.
    Bennett M; Parkash R; Nery P; Sénéchal M; Mondesert B; Birnie D; Sterns LD; Rinne C; Exner D; Philippon F; Campbell D; Cox J; Dorian P; Essebag V; Krahn A; Manlucu J; Molin F; Slawnych M; Talajic M
    Can J Cardiol; 2017 Feb; 33(2):174-188. PubMed ID: 28034580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death.
    Tung R; Zimetbaum P; Josephson ME
    J Am Coll Cardiol; 2008 Sep; 52(14):1111-21. PubMed ID: 18804736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indications for pacemakers, implantable cardioverter-defibrillator and cardiac resynchronization devices.
    Samii SM
    Med Clin North Am; 2015 Jul; 99(4):795-804. PubMed ID: 26042883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sudden cardiac death, ICD and resynchronization therapy].
    Schaumann A; Tack C; Kuck KH
    Herz; 2006 Dec; 31(9):857-63. PubMed ID: 17180648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.